Home » Stocks » MannKind Corporation

MannKind Corporation (MNKD)

Stock Price: $1.67 USD -0.20 (-10.48%)
Updated Aug 6, 2020 12:23 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 354.87M
Revenue (ttm) 61.83M
Net Income (ttm) -46.34M
Shares Out 213.14M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $1.67
Previous Close $1.86
Change ($) -0.20
Change (%) -10.48%
Day's Open 1.66
Day's Range 1.60 - 1.72
Day's Volume 2,725,372
52-Week Range 0.80 - 2.48

More Stats

Market Cap 354.87M
Enterprise Value 436.86M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 213.14M
Float 202.46M
EPS (basic) -0.23
EPS (diluted) -0.23
FCF / Share -0.43
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 31.21M
Short Ratio 5.37
Short % of Float 15.02%
Beta 2.25
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 5.74
PB Ratio n/a
Revenue 61.83M
Operating Income -39.98M
Net Income -46.34M
Free Cash Flow -90.55M
Net Cash -81.99M
Net Cash / Share -0.38
Gross Margin 56.71%
Operating Margin -64.66%
Profit Margin -75.00%
FCF Margin -146.46%
ROA -26.53%
ROE n/a
ROIC -32.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$3.00*
(80.18% upside)
Low
2.50
Current: $1.67
High
4.00
Target: 3.00
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue63.0427.8611.75175---0.040.050.09
Revenue Growth126.28%137.2%-93.28%-----30%-46.24%-
Gross Profit35.067.39-5.48125-64.75--0.040.050.09
Operating Income-46.51-81.06-94.5563.83-342-180-169-147-141-152
Net Income-51.90-86.98-117126-368-198-191-169-161-171
Shares Outstanding19614410492.0581.2377.0559.9236.1724.3622.73
Earnings Per Share-0.27-0.60-1.131.36-4.54-2.57-3.20-4.70-6.60-7.50
Operating Cash Flow-88.48-37.73-64.78-78.09-57.234.09-129-120-124-149
Capital Expenditures-2.57-0.230.02-1.13-10.20-24.10-7.99-0.56-6.77-9.54
Free Cash Flow-91.05-37.97-64.75-79.22-67.44-20.01-137-120-131-158
Cash & Equivalents50.2071.6848.3622.9059.0712170.7961.842.6870.43
Total Debt121102157148214225250332488445
Net Cash / Debt-71.21-30.80-108-126-155-104-179-270-485-374
Assets93.7310884.58107126394259251200277
Liabilities284283299291477468289362513463
Book Value-191-175-215-184-350-73.77-30.71-111-314-186
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MannKind Corporation
Country United States
Employees 232
CEO Michael E. Castagna

Stock Information

Ticker Symbol MNKD
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MNKD
IPO Date July 28, 2004

Description

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.